Efficacy of Flomax to Improve Stone Passage Following Shock Wave Lithotripsy
Efficacy of Flomax to Improve Stone Passage Following Shock Wave Lithotripsy
The majority of kidney stones are treated with shock wave lithotripsy (SWL). We are examining
 if the medication Flomax will result in improved stone passage rates following SWL.
Placebo blinded study examining the effects of Flomax on stone passage rates following SWL.
Inclusion Criteria:

 -  Patients 18 years old and above with urolithiasis scheduled for shock wave
 lithotripsy.

 Exclusion Criteria:

 -  Contraindications to Flomax

 -  Patients with renal impairment (serum creatinine above 2.0)

 -  Patients with hepatic impairment (liver enzymes 2.5 times the upper limit of normal)

 -  Use of other oral alpha blockers